Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer

Abstract

BackgroundMounting evidence suggests a causal relationship between specific bacterial infections and the development of certain malignancies. However, the possible role of the keystone periodontal pathogen, Porphyromonas gingivalis, in esophageal squamous cell carcinoma (ESCC) remains unknown. Therefore, we examined the presence of P. gingivalis in esophageal mucosa, and the relationship between P. gingivalis infection and the diagnosis and prognosis of ESCC.MethodsThe presence of P. gingivalis in the esophageal tissues from ESCC patients and normal controls was examined by immunohistochemistry using antibodies targeting whole bacteria and its unique secreted protease, the gingipain Kgp. qRT-PCR was used as a confirmatory approach to detect P. gingivalis 16S rDNA. Clinicopathologic characteristics were collected to analyze the relationship between P. gingivalis infection and development of ESCC.ResultsP. gingivalis was detected immunohistochemically in 61 % of cancerous tissues, 12 % of adjacent tissues and was undetected in normal esophageal mucosa. A similar distribution of lysine-specific gingipain, a catalytic endoprotease uniquely secreted by P. gingivalis, and P. gingivalis 16S rDNA was also observed. Moreover, statistic correlations showed P. gingivalis infection was positively associated with multiple clinicopathologic characteristics, including differentiation status, metastasis, and overall survival rate.ConclusionThese findings demonstrate for the first time that P. gingivalis infects the epithelium of the esophagus of ESCC patients, establish an association between infection with P. gingivalis and the progression of ESCC, and suggest P. gingivalis infection could be a biomarker for this disease. More importantly, these data, if confirmed, indicate that eradication of a common oral pathogen could potentially contribute to a reduction in the overall ESCC burden.Electronic supplementary materialThe online version of this article (doi:10.1186/s13027-016-0049-x) contains supplementary material, which is available to authorized users.

Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc

“…Porphyromonas gingivalis , is an oral Gram-negative, anaerobic periodontal bacterium (Hajishengallis et al, 2011) that was previously found to be overabundant in gingival squamous cell carcinoma (Gao et al, 2016; Katz et al, 2011; Whitmore and Lamont, 2014). When mice were intravenously inoculated with P. gingivalis , its levels in tumors are below the limit of detection both by culturing (~10 CFU/gr tissue) and qPCR (Figures 5D and 5E).…”

Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers

“…the species most strongly associated with severe periodontitis (30). A recent report revealed that Porphyromonas gingivalis was detected at a higher rate in ESCC tumor tissue, compared to adjacent normal and healthy control mucosa; moreover, Porphyromonas gingivalis presence was associated with ESCC lymph node metastasis and decreased survival time (39). More research is needed to determine whether periodontal disease and/or periodontal pathogens play a role in EAC/ESCC carcinogenesis, particularly since periodontal pathogen-EAC risk associations were inconsistent between the CPS-II and PLCO cohorts.…”

Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications

“…Another study using 16S rDNA sequencing technology demonstrated that, relative to controls, the gastric corpus microbiota of patients affected by esophageal squamous dysplasia and esophageal squamous cell carcinoma are enriched in Clostridiales and Erysipelotrichales, suggesting that gastric dysbiosis is involved in the progression from esophageal squamous dysplasia to squamous cell carcinoma 61. Gao et al 62. revealed that a specific microbiome Porphyromonas gingivalis infects the cancerous and adjacent esophageal mucosa of esophageal squamous cell carcinoma patients but not the healthy mucosa of controls, supporting a pathogenesis role of this organism in esophageal squamous cell carcinoma.…”